Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.22 million. The enterprise value is -463,431.
| Market Cap | 1.22M |
| Enterprise Value | -463,431 |
Important Dates
The next estimated earnings date is Wednesday, October 14, 2026.
| Earnings Date | Oct 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has increased by 16.28% in one year.
| Current Share Class | 7.42M |
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | +16.28% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 7.91% |
| Float | 7.27M |
Valuation Ratios
The trailing PE ratio is 1.35.
| PE Ratio | 1.35 |
| Forward PE | n/a |
| PS Ratio | 0.10 |
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.94 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 4.55 |
| Debt / FCF | n/a |
| Interest Coverage | 6.06 |
Financial Efficiency
Return on equity (ROE) is 102.33% and return on invested capital (ROIC) is 0.61%.
| Return on Equity (ROE) | 102.33% |
| Return on Assets (ROA) | 0.40% |
| Return on Invested Capital (ROIC) | 0.61% |
| Return on Capital Employed (ROCE) | 0.67% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | 326,568 |
| Profits Per Employee | 51,598 |
| Employee Count | 39 |
| Asset Turnover | 1.80 |
| Inventory Turnover | 3.70 |
Taxes
| Income Tax | -1.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.13% in the last 52 weeks. The beta is 0.49, so Escalon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +3.13% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 48.52 |
| Average Volume (20 Days) | 12,618 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.74 million and earned 2.01 million in profits. Earnings per share was 0.27.
| Revenue | 12.74M |
| Gross Profit | 5.57M |
| Operating Income | 45,235 |
| Pretax Income | 2.87M |
| Net Income | 2.01M |
| EBITDA | 67,823 |
| EBIT | 45,235 |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 3.07 million in cash and 974,740 in debt, with a net cash position of 2.09 million or 0.28 per share.
| Cash & Cash Equivalents | 3.07M |
| Total Debt | 974,740 |
| Net Cash | 2.09M |
| Net Cash Per Share | 0.28 |
| Equity (Book Value) | 5.93M |
| Book Value Per Share | 0.71 |
| Working Capital | 4.62M |
Cash Flow
In the last 12 months, operating cash flow was -402,604 and capital expenditures -4,421, giving a free cash flow of -407,025.
| Operating Cash Flow | -402,604 |
| Capital Expenditures | -4,421 |
| Depreciation & Amortization | 28,139 |
| Net Borrowing | -135,924 |
| Free Cash Flow | -407,025 |
| FCF Per Share | -0.05 |
Margins
Gross margin is 43.73%, with operating and profit margins of 0.36% and 31.51%.
| Gross Margin | 43.73% |
| Operating Margin | 0.36% |
| Pretax Margin | 22.56% |
| Profit Margin | 31.51% |
| EBITDA Margin | 0.53% |
| EBIT Margin | 0.36% |
| FCF Margin | n/a |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -16.28% |
| Shareholder Yield | -16.28% |
| Earnings Yield | 164.47% |
| FCF Yield | -33.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |